scispace - formally typeset
Search or ask a question

Showing papers by "Shigeki Momohara published in 2019"

Journal Article•DOI•
Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study

[...]

Tsuneyo Mimori1, Masayoshi Harigai, Tatsuya Atsumi2, Takao Fujii3, Masataka Kuwana4, Hiroaki Matsuno, Shigeki Momohara5, Syuji Takei6, Naoto Tamura7, Yoshinari Takasaki7, Kazuhiko Yamamoto, Satoshi Ikeuchi8, Satoru Kushimoto, Takao Koike •
Kyoto University1, Hokkaido University2, Wakayama Medical University3, Nippon Medical School4, Keio University5, Kagoshima University6, Juntendo University7, Eisai8
01 Mar 2019-Modern Rheumatology
TL;DR: Long-term treatment with IGU in patients with RA resulted in a tolerable safety profile and an improvement in RA activity, and IGU could be considered a useful treatment option for patients withRA.
Abstract: Objectives: We evaluated the long-term (52 weeks) safety and effectiveness of iguratimod (IGU) in patients with rheumatoid arthritis (RA).Methods: This multicenter, prospective, observational study...

26 citations